Differential Treatment Response to Insulin Intensification Therapy: A Post Hoc Analysis of a Randomized Trial Comparing Premixed and Basal-Bolus Insulin Regimens

ConclusionsThe preliminary results showed that the subgroup of patients with race other than Caucasian and FBG<8.89  mmol/L may respond better to premixed intensification therapy. This result provides some preliminary information for further investigation in prospective studies.FundingEli Lilly and Company.Clinical Trial RegistrationClinicaltrials.gov ID number: NCT00110370.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research